Principal Investigator

PI

PRINCIPAL INVESTIGATOR

Mychael V. Lourenco, Ph.D.

Assistant Professor – Institute of Medical Biochemistry Leopoldo de Meis | Universidade Federal do Rio de Janeiro

 

Visiting Scientist – Department of Biochemistry and Tissue Biology | State University of Campinas, Brazil

Selected

Awards

2023 – Distinguished Researcher – Brazil Conference

2022 – 11 Early Career Scientist to Watch – Nature Medicine

2022 – Blas Frangione Early Career Achievement Award – Alzheimer’s Association

2021 – IBRO Early Career Award – International Brain Research Organization

2021 – Affiliate Member of the Brazilian Academy of Sciences

2020 – Young IBRO Regions Connecting Award – International Brain Research Organization

2017 – 1st SBBq/Biozeus Innovation Prize, Brazilian Society for Biochemistry and Molecular Biology, Brazil

2017 – Vital Brazil Best PhD Thesis Award – Biological, Health and Agricultural Sciences, Brazilian Federal Foundation for Higher Education (CAPES) – Ministry of Education

2017 – Finalist – 21st Young Talent Award in Life Sciences, Brazilian Society for Biochemistry and Molecular Biology, Brazil

2016 – Finalist – 20th Young Talent Award in Life Sciences, Brazilian Society for Biochemistry and Molecular Biology, Brazil

About

Mychael

Mychael received his B.Sc. degree in Genetics (2010), his MSc (2012) and PhD (2016) from the Federal University of Rio de Janeiro, where he further conducted his postdoctoral training. He has been a visiting collaborator at Columbia University (NYC) and is an Assistant Professor of Neuroscience at the Institute of Medical Biochemistry Leopoldo de Meis (Federal University of Rio de Janeiro). He is a Productivity Fellow Level 2 of the Brazilian Council for Scientific Research and Development (CNPq PQ2), an Young Scientist Fellow of the Rio de Janeiro State Science Agency (Jovem Cientista FAPERJ) and an Affiliate Member of the Brazilian Academy of Sciences. 

Mychael is a senior editor at the Journal of Neurochemistry and Alzheimer’s & Dementia: Translational Research and Clinical Investigations. He has served on several society committees, including the SfN’s Trainee Advisory Committee (2016-2019) and Online Program Steering Committee (2017-2021), Global Membership Committee (2022-current) and the Young Scientist Steering Committee of the International Society for Neurochemistry (2017-2021).

With extensive experience in cellular and molecular neuroscience, Mychael’s research focuses on the molecular mechanisms underlying Alzheimer’s disease. His work in the laboratories of Fernanda De Felice and Sergio Ferreira has led to the identification of mechanisms causing neuronal stress and memory loss in AD models. The Lourenco Lab aims to elucidate the molecular mechanisms of cognitive dysfunction associated with neurological diseases and identify potential targets for effective therapeutic interventions.